{
  "kind": "framework",
  "value": "inverted-u-dose-response",
  "collectionKey": "slides:framework:inverted-u-dose-response:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 2,
  "page": 1,
  "pageSize": 24,
  "pageCount": 1,
  "rows": [
    {
      "docId": "019de074-ad31-7288-aa0c-b4a964d6a9af",
      "docSlug": "31aafddb38d645745d1c40d83b8ae135",
      "documentTitle": "ATAI | Investor Presentation Deck | 30 slides",
      "authorId": "atai",
      "authorName": "atai",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-04-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide highlights the 'inverted-U' dose-response curve, a key pharmacological characteristic for this drug candidate.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Explicitly mentioned in title and bullet points",
      "slideHref": "/slides/019de074-ad31-7288-aa0c-b4a964d6a9af/11",
      "deckHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af",
      "deckAnchorHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af#slide-11",
      "loopMatches": [
        {
          "to": 30,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "8a640552-7d64-4f46-af4c-8041a39da251",
          "evidence": "The deck presents a clear and compelling vision for ATAI's mission and solution",
          "position": 1,
          "objective": "Present a compelling vision for ATAI's mission and solution",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 9,
          "beatId": "ac5e080c-b74d-4115-a83a-25ce54f0c50b",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 9-24 present traction data for various programs",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide demonstrates an inverted U-shaped dose response curve.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Mentioned in key takeaway #3",
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/27",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-27",
      "loopMatches": [
        {
          "to": 34,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf",
          "evidence": "The deck emphasizes the need for effective treatments",
          "position": 0,
          "objective": "Highlight the importance of addressing mental health disorders",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 34,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5",
          "evidence": "The deck follows a structure that aligns with the Golden Circle",
          "position": 1,
          "objective": "Explain the company's approach and solution",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}